本页面由Tiger Trade Technology Pte. Ltd.提供服务

Lyra Therapeutics, Inc.

0.6600
0.0000
成交量:5,596.00
成交额:3,693.36
市值:117.14万
市盈率:-0.03
高:0.6600
开:0.6600
低:0.6600
收:0.6600
52周最高:37.50
52周最低:0.3100
股本:177.49万
流通股本:132.37万
量比:0.53
换手率:0.42%
股息:- -
股息率:- -
每股收益(TTM):-22.9324
每股收益(LYR):-71.7474
净资产收益率:-6594.98%
总资产收益率:-36.06%
市净率:-0.11
市盈率(LYR):-0.01

数据加载中...

2023/06/13

超过5%披露

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
2023/06/09

超过5%披露

Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
2023/06/02

超过5%披露

Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
2023/06/01

重要事件披露

Form 8-K - Current report
2023/05/12

重要事件披露

8-K - Current report
2023/05/12

季度报告

10-Q - Quarterly report [Sections 13 or 15(d)]
2023/03/29

年度报告

10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2023/03/29

员工持股计划

S-8 - Securities to be offered to employees in employee benefit plans
2023/03/29

重要事件披露

8-K - Current report
2023/02/14

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2023/02/14

超过5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2023/02/13

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2023/02/07

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2022/11/16

重要事件披露

8-K - Current report
2022/11/08

重要事件披露

8-K - Current report
2022/11/08

季度报告

10-Q - Quarterly report [Sections 13 or 15(d)]
2022/11/02

[修订]季度报告

10-Q/A [Amend] - Quarterly report [Sections 13 or 15(d)]
2022/11/02

[修订]季度报告

10-Q/A [Amend] - Quarterly report [Sections 13 or 15(d)]
2022/10/26

重要事件披露

8-K - Current report
2022/09/12

重要事件披露

8-K - Current report